Dental abutment including fillet
US-9248008-B2 · Feb 2, 2016 · US
US9889237B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9889237-B2 |
| Application number | US-201313875355-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 2, 2013 |
| Priority date | May 11, 2012 |
| Publication date | Feb 13, 2018 |
| Grant date | Feb 13, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A medical device has a surface intended for contact with living tissue, wherein the surface comprises nanoparticles comprising a non-toxic post-transition metal such as gallium and/or bismuth, said nanoparticles having an average particle size of 500 nm or less. The nanoparticles may provide an antimicrobial effect, and thus the risk for infection may be reduced.
Opening claim text (preview).
The invention claimed is: 1. A medical device, which is a dental implant intended for implantation at least partially into living tissue, said dental implant comprising a non-bioresorbable substrate having a surface intended for contact with living tissue, wherein the surface includes a homogenous monolayer of nanoparticles comprising titanium dioxide, bismuth nitride, and gallium nitride, the monolayer of nanoparticles having a thickness from 100 nm to 400 nm with said nanoparticles having an average particle size of 500 nm or less. 2. The medical device according to claim 1 , wherein said nanoparticles of titanium dioxide have an average particle size of 100 nm or less. 3. The medical device according to claim 1 , wherein said medical device comprises a substrate having said surface, which substrate comprises a metal or an alloy. 4. The medical device according to claim 3 , wherein said substrate comprises titanium, zirconium, hafnium, vanadium, niobium, tantalum, cobalt or iridium, or an alloy thereof. 5. The medical device according to claim 1 , wherein the dental implant is a dental fixture intended to be inserted at least partially into living bone tissue. 6. The medical device according to claim 1 , wherein the dental implant is a dental abutment, intended to be in contact with living soft tissue. 7. A method of implanting a medical device into the living body of a human or animal, the method comprising: a) providing a medical device according to claim 1 ; and b) implanting said medical device into said living body of a human or animal, wherein the medical device is positioned such that at least part of the surface comprising nanoparticles comprising a non-toxic post-transition metal is in contact with living tissue.
Other specific inorganic materials not covered by A61L27/303 - A61L27/32 · CPC title
Inorganic materials · CPC title
Inorganic materials · CPC title
Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools (fastening of peg-teeth in the mouth A61C13/30) · CPC title
for dental implants or prostheses · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.